<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://tobaccocontrol.bmj.com">
<title>Tobacco Control current issue</title>
<link>http://tobaccocontrol.bmj.com</link>
<description>Tobacco Control RSS feed -- current issue</description>
<prism:coverDisplayDate>May  1 2026 12:00:00:000AM</prism:coverDisplayDate>
<prism:publicationName>Tobacco Control</prism:publicationName>
<prism:issn>0964-4563</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/281?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/285?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/289?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/298?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/307?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/314?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/320?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/331?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/337?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/345?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/351?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/358?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/366?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/375?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/382?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/391?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/404?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/408?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/412?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/415?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/417?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/419?rss=1" />
  <rdf:li rdf:resource="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/421?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://tobaccocontrol.bmj.com/site/homepage/TC_95x60.gif" />
</channel>
<image rdf:about="http://tobaccocontrol.bmj.com/site/homepage/TC_95x60.gif">
<title>Tobacco Control</title>
<url>http://tobaccocontrol.bmj.com/site/homepage/TC_95x60.gif</url>
<link>http://tobaccocontrol.bmj.com</link>
</image>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/281?rss=1">
<title><![CDATA[What the assault on the US Centers for Disease Controls Office on Smoking and Health means for the USA and Global Public Health]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/281?rss=1</link>
<description><![CDATA[ <p>On 1 April 2025, the Office on Smoking and Health (OSH), a division in the US Centers for Disease Control and Prevention (CDC), was shuttered. Some 200 staff and contractors discovered via a middle of the night email that they were terminated without notice.<cross-ref type="bib" refid="R1">1</cross-ref> OSH&rsquo;s dismantling has continued, including withholding of funding appropriated by Congress to support state tobacco programmes for half a year and ending the astonishingly successful 14-year <I>Tips From Former Smokers</I> national media campaign. Surveillance systems that inform our understanding of tobacco use and cessation trends have been degraded.<cross-ref type="bib" refid="R2">2 3</cross-ref><cross-ref type="bib" refid="R3"></cross-ref> These developments, combined with cutbacks in related US federal programmes and discontinuation of US funding for the WHO&mdash;long a thorn in the side of the tobacco industry&mdash;place coordinated tobacco prevention efforts and progress in reducing tobacco harms in the USA at risk. Unless reversed, they may also potentially impact global...]]></description>
<dc:creator><![CDATA[McAfee, T.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2026-060273</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2026-060273</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[What the assault on the US Centers for Disease Controls Office on Smoking and Health means for the USA and Global Public Health]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Editorial</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>281</prism:startingPage>
<prism:endingPage>284</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/285?rss=1">
<title><![CDATA[Worldwide news and comment]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/285?rss=1</link>
<description><![CDATA[ <p><textbox id="BWL1"><p>All articles written by Ruth Canty unless otherwise attributed. Ideas and items for News Analysis should be sent to ruth. canty@flinders.edu.au</p> </textbox></p> <sec id="s1"><st>Behind closed doors: tobacco industry lobbying in the EU aims to weaken health policies worldwide</st> <p>A new report, <A HREF="https://exposetobacco.org/campaigns/behind-closed-doors/">Behind Closed Doors: How the Tobacco Lobby Influences the European Union</inter-ref><inter-ref locator="https://exposetobacco.org/campaigns/behind-closed-doors/" locator-type="url"> and Beyond</A>, exposes the scale and tactics of well-resourced, coordinated tobacco industry lobbying at the heart of decision-making within the European Union (EU) and its current focus on increasing the availability of the industry&rsquo;s addictive, harmful products. Drawing on analysis of EU transparency registers, other public records and extensive freedom of information (FOI) requests, our analysis reveals a concerted effort by tobacco companies&mdash;particularly Philip Morris International (PMI)&mdash;to both influence EU policy and leverage the EU&rsquo;s diplomatic and trade power to undermine policy well beyond Europe&rsquo;s borders.</p> <p>The report reveals that industry influence...]]></description>
<dc:creator><![CDATA[Canty, R.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2026-060274</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2026-060274</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[TC News analysis]]></dc:subject>
<dc:title><![CDATA[Worldwide news and comment]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>News analysis</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>285</prism:startingPage>
<prism:endingPage>288</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/289?rss=1">
<title><![CDATA[Effect of electronic cigarette atomising power and flavour on aerosol size-segregated metal concentration and inhalation risk]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/289?rss=1</link>
<description><![CDATA[
<sec><st>Introduction</st>
<p>Although numerous studies have estimated the inhalation dose of metals emitted from electronic cigarettes (e-cigs), the impact of factors including aerosol size and the atomising power of e-cig aerosols on estimating the inhalation dose of metals remains underexplored. A comprehensive understanding of these determinants is essential to assess the health risks associated with inhaling e-cig aerosols, which may contain potentially harmful metals.</p>
</sec>
<sec><st>Objectives</st>
<p>The aim of this study is to elucidate the mass and inhalation doses of potentially harmful metals in e-cig aerosols by different particle size and their association with the various atomising powers of e-cig devices and flavours.</p>
</sec>
<sec><st>Methods</st>
<p>Size-segregated e-cig aerosols were generated and collected in a exposure chamber, using an 11-stage cascade impactor for the analyses of aerosol mass and metals. The metal deposition dose in the human respiratory tract was calculated using a mathematical respiratory deposition estimation model and metal mass concentration by the size of aerosols.</p>
</sec>
<sec><st>Results</st>
<p>In this study, the results showed that neither an increase in atomising power (from 5 to 20 W) nor e-cig flavours resulted in a significant increase in a metal deposition in the respiratory tracts. Although the factors did not significantly affect the calculated respiratory deposition of harmful metals under typical e-cig usage assumption, the estimated hazard index exceeded 1.0.</p>
</sec>
<sec><st>Conclusion</st>
<p>The calculated health risks suggest substantial risks of inhalation of metal aerosols from e-cig use.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Lee, J., Afshar, M., Su, W.-C., Han, I.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2024-058915</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2024-058915</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Effect of electronic cigarette atomising power and flavour on aerosol size-segregated metal concentration and inhalation risk]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Original research</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>289</prism:startingPage>
<prism:endingPage>297</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/298?rss=1">
<title><![CDATA[Quantile regression of tobacco tax pass-through in the UK 2017-2021: how have manufacturers passed through tax changes for different tobacco products in small retailers? Analysis at the national level and by neighbourhood of deprivation]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/298?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>The effectiveness of tax increases in reducing tobacco consumption relies on the tobacco retailers and producers passing on increases to consumers (tax pass-through). Previous UK research on supermarkets found heterogeneous levels of tax pass-through across the market segments and price distribution of tobacco products. This study uses data from small retailers across the UK to assess whether recent tax changes have been passed on to consumers and if this varies across the price distribution, between countries of the UK and by neighbourhood deprivation.</p>
</sec>
<sec><st>Methods</st>
<p>We use panel data quantile regression analysis of tobacco sales in small retailers in the UK from March 2017 to December 2021 combined with UK tax rates and store-level index of multiple deprivation (IMD). We calculated the rate of tax pass-through for factory-made cigarettes (FM) and roll-your-own tobacco (RYO).</p>
</sec>
<sec><st>Results</st>
<p>Following increases in the duty payable on tobacco, we find evidence of overshifting across the entire price distribution for FM and RYO. For England, Scotland and Wales, the rate of the overshift in tax increased with product price. For Scotland, we find that stores in the least deprived IMD pass-through taxes at a higher rate.</p>
</sec>
<sec><st>Conclusions</st>
<p>Our evidence shows heterogeneous levels of tax pass-through by price, region and level of deprivation. The findings emphasise the importance of understanding the pricing strategies of the tobacco industry (TI) and how these vary across the UK to develop robust approaches to mitigate the pricing strategies of the TI.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Wilson, L. B., Angus, C., Brennan, A., Gillespie, D., Shortt, N. K., Tunstall, H., Valiente, R., Pearce, J.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2024-058958</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2024-058958</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Open access]]></dc:subject>
<dc:title><![CDATA[Quantile regression of tobacco tax pass-through in the UK 2017-2021: how have manufacturers passed through tax changes for different tobacco products in small retailers? Analysis at the national level and by neighbourhood of deprivation]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Original research</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>298</prism:startingPage>
<prism:endingPage>306</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/307?rss=1">
<title><![CDATA[Australian adolescents knowledge of smoking harms and misperceptions about tobacco products: a cross-sectional study]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/307?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To assess adolescents&rsquo; baseline knowledge of smoking health harms scheduled to be covered in future graphic health warnings (GHWs) and inform the content of future tobacco control public communication campaigns.</p>
</sec>
<sec><st>Methods</st>
<p>Cross-sectional survey of 8631 secondary school students (mean age=14.5 years) in Australia in 2022/2023 (weighted n=8655). Students were asked (a) for their agreement/disagreement that smoking causes each of nine harms (eg, lung cancer, stomach cancer and asthma), (b) to indicate where most of smoking&rsquo;s harmful chemicals come from and (c) for their agreement/disagreement concerning the relative harmfulness of different tobacco product attributes (eg, menthol and roll-your-own). Multivariable logistic regression analyses examined associations between students&rsquo; knowledge and perceptions and their smoking status, controlling for demographics and school-level clustering.</p>
</sec>
<sec><st>Results</st>
<p>Students had greater awareness of harms previously publicised in Australia. Among students who had never smoked, those open to future smoking had lower awareness of six smoking harms than those with a firm future intention not to smoke. Only 17.8% of all students were aware that most harmful chemicals came from burning the tobacco, with 37.8% not knowing and 34.6% attributing the source to additives. Three-quarters held misperceptions that roll-your-own cigarettes are less harmful than factory-made cigarettes or that cigarette smoke which feels light or smooth is less harmful than smoke that feels harsh. Only 25.9% of students were aware that menthol cigarettes are more addictive than non-menthol cigarettes.</p>
</sec>
<sec><st>Discussion</st>
<p>New GHWs and public communication campaigns could improve student knowledge of previously unpublicised smoking harms and counter pervasive misperceptions about tobacco products.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Scully, M., Wakefield, M. A., Baker, E., Koh, I., Scollo, M., Brennan, E., White, V. M., Durkin, S. J.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2024-059083</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2024-059083</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Australian adolescents knowledge of smoking harms and misperceptions about tobacco products: a cross-sectional study]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Original research</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>307</prism:startingPage>
<prism:endingPage>313</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/314?rss=1">
<title><![CDATA[Incidence, mortality and oral cancer disability-adjusted life years in 204 countries and territories before and after the adoption of FCTC/WHO: interrupted time series study]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/314?rss=1</link>
<description><![CDATA[
<p>The development of oral cancer (OC) is strongly associated with tobacco products which is a significant risk factor. In 2003, the WHO recommended that countries adopt the Framework Convention on Tobacco Control (FCTC/WHO), an international treaty that includes a set of public policies for tobacco control. Studies show a reduction in the prevalence of tobacco product consumption in countries that have more strongly implemented WHO/FCTC actions. However, information on the relationship between these policies and the burden of neoplastic diseases, including OC, is still scarce. For this reason, the objective of this study was to analyse trends in incidence, mortality, and OC disability-adjusted life years (DALYs) in countries and territories that have joined FCTC/WHO. The analysis lasted from 1990 to 2019, and 2003 was the interruption year (FCTC/WHO implementation), characterising the interrupted time series. The control group (G1) was composed of the countries and territories that did not adhere to the FCTC/WHO; the countries and territories that joined FCTC/WHO were divided into two groups, according to their policy performance (G2A: lowest MPOWER score and G2B: highest MPOWER score). To analyse trends and slopes, generalised linear regression was used using the Prais-Winsten method, allowing the presentation by means of the annual percentage changes and their respective 95% CIs. The temporal pattern showed significant downward negative movements in the group of countries and territories with the highest performance of the policies established in the FCTC/WHO (G2B Group). The socioeconomic development of the countries and territories did not interfere with the impact on the OC rates. It is concluded that the effective implementation of public policies for tobacco control is capable of favourably modifying the trend of incidence, mortality and DALYs rates of OC.</p>
]]></description>
<dc:creator><![CDATA[Silva, B. M. d., Hagen, L. M., Cunha, A. R. d., Hugo, F. N., Amenabar, J. M.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2024-058882</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2024-058882</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Editor's choice]]></dc:subject>
<dc:title><![CDATA[Incidence, mortality and oral cancer disability-adjusted life years in 204 countries and territories before and after the adoption of FCTC/WHO: interrupted time series study]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Original research</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>314</prism:startingPage>
<prism:endingPage>319</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/320?rss=1">
<title><![CDATA[Characteristics of users of French smoking cessation services from 2004 to 2018]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/320?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>We investigated changes in the profile of persons who smoke (PWS) seeking assistance from smoking cessation services (SCS) in France between 2004 and 2018, aligning with national policies.</p>
</sec>
<sec><st>Methods</st>
<p>A prospective study of 131 280 adult PWS was conducted across three periods: 2004&ndash;2008 (during a 42% increase in tobacco prices), 2009&ndash;2013 (following a tobacco sales ban to minors) and 2014&ndash;2018 (marking the first national antismoking policy). Sociodemographic and medical characteristics, smoking behaviours and prescribed cessation medications were analysed cross-sectionally at the first consultation.</p>
</sec>
<sec><st>Results</st>
<p>Between 2004&ndash;2008 and 2014&ndash;2018, the mean age of SCS attendees increased from 44 to 47 years (p&lt;0.001). Concurrently, the proportion of PWS without a school diploma rose from 19% to 22%, and unemployed PWS from 13% to 22% (both p&lt;0.001). Smoking-related cancer prevalence doubled from 3% to 6% (p&lt;0.001). The proportion of PWS with no prior quit attempts increased from 31% in 2004&ndash;2008 to 35% in 2014&ndash;2018 (p&lt;0.001). There was also a notable decline in those attending SCS on a personal initiative, dropping from 45% to 35% (p&lt;0.001). Mean number of cigarettes smoked daily was stable at 23 between 2004 and 2018. Combination nicotine replacement therapy remained the most prescribed cessation medication, accounting for 44% of treatments during this period.</p>
</sec>
<sec><st>Conclusions</st>
<p>Despite tobacco control efforts between 2004 and 2018, challenges persist in reducing smoking behaviours in France. Increased SCS utilisation among older adults and individuals with lower socioeconomic status underscores the importance of enhancing SCS availability in France to support the various profiles of PWS.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Allagbe, I., Menard, J., Le Faou, A.-L.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2024-058795</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2024-058795</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Characteristics of users of French smoking cessation services from 2004 to 2018]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Original research</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>320</prism:startingPage>
<prism:endingPage>330</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/331?rss=1">
<title><![CDATA[Psychological, social and cultural influences on smoking among lesbian, bisexual and queer women]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/331?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>Smoking rates have declined markedly in Australia over time; however, lesbian, bisexual and queer (LBQ) women continue to smoke at higher rates than heterosexual women. Understanding the factors influencing smoking in this population is crucial for developing targeted cessation interventions and other supports.</p>
</sec>
<sec><st>Methods</st>
<p>Experiences of and motivations for smoking among 42 LBQ cisgender and transgender women and non-binary people in Australia who currently or previously smoked were explored through semi-structured interviews. Participants were primarily white Australian cisgender women in their 30s&ndash;40s. Thematic analysis was used to identify common psychological, social and cultural influences on smoking.</p>
</sec>
<sec><st>Results</st>
<p>While coping with minority stress was a common factor influencing some participants&rsquo; smoking behaviours, participants also described how smoking offered pleasurable opportunities for gender expression, affirmation and rebellion. Smoking also enabled participants to experience &lsquo;marginalised connectivity&rsquo;, a form of social solidarity fostered through the sharing of a stigmatised practice by an oppressed or stigmatised community.</p>
</sec>
<sec><st>Conclusion</st>
<p>This article identifies factors contributing to the ongoing socio-cultural relevance of smoking for some LBQ women in Australia. These specific psychological, social and cultural contexts remain salient for LBQ women&rsquo;s smoking and must be factored into smoking cessation campaigns and programme designs for this population. Tailored messaging that emphasises alternative self-care strategies and the benefits of quitting in the context of supportive communities may be more effective in engaging LBQ women than long-term health risk messages.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Grant, R., Mooney-Somers, J., McNair, R., Pennay, A., Segan, C., Power, J., Bourne, A.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2024-059039</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2024-059039</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Psychological, social and cultural influences on smoking among lesbian, bisexual and queer women]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Original research</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>331</prism:startingPage>
<prism:endingPage>336</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/337?rss=1">
<title><![CDATA[Cessation and knowledge-building messaging are associated with e-cigarette cessation intentions among youth and young adults in the USA]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/337?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>Increasing intentions to quit e-cigarettes among youth and young adults can reduce usage rates by making quit attempts more likely. This study assessed the potential impacts of a national media campaign, focused on building knowledge of e-cigarette use risks and cessation resources, on intentions to quit and campaign-targeted beliefs about mental health and quitting.</p>
</sec>
<sec><st>Methods</st>
<p>A national sample from a repeated cross-sectional online survey was collected from March 2022 to August 2023, among youth and young adults who reported e-cigarette use in the past 30 days (N=5169). Regression models were used to assess associations between weekly campaign awareness and frequency of exposure on intentions to quit e-cigarette use within the next 6 months and targeted beliefs related to mental health and quitting.</p>
</sec>
<sec><st>Results</st>
<p>Participants who were aware of both cessation and knowledge-building messaging were more likely to report intentions to quit e-cigarette use in the next 6 months (OR 1.43, (95% CI 1.21, 1.69)) and agree with quitting-related targeted beliefs (ORs 1.35&ndash;1.63) and a mental health targeted belief scale (b=1.14 (95% CI 0.69, 1.59)), relative those with no messaging awareness. The frequency of exposure to cessation messaging held a dose-response relationship with almost all outcomes.</p>
</sec>
<sec><st>Conclusion</st>
<p>Findings suggest that frequency and awareness of messaging that educates about e-cigarette harms to mental health and about cessation resources are associated with higher quitting intentions among young people who use e-cigarettes.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Yu, L. Q., Do, E. K., Minter, T., Koris, K., Khatib, B., Jacobs, M. A., Graham, A. L., Hair, E. C.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2024-058821</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2024-058821</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Cessation and knowledge-building messaging are associated with e-cigarette cessation intentions among youth and young adults in the USA]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Original research</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>337</prism:startingPage>
<prism:endingPage>344</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/345?rss=1">
<title><![CDATA[Trends in use of cigarettes and e-cigarettes among young adults who had smoked in adolescence: 2017-2022]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/345?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>This study considers recent trends in combustible and e-cigarette use among US young adults who smoked cigarettes in adolescence, who are the originating source of most adults who smoke.</p>
</sec>
<sec><st>Methods</st>
<p>Data come from the Monitoring the Future study, which includes young adults aged 19&ndash;30 who were first surveyed in 12th grade as part of a nationally-representative sample. The analysis centres on 3623 observations from 2377 young adults surveyed from 2017 to 2022 who reported they had ever smoked a combustible cigarette in the initial, 12th grade survey.</p>
</sec>
<sec><st>Results</st>
<p>Among young adults who had smoked in adolescence, the percentage who used a combustible cigarette currently (in the past 30 days) significantly declined from 45% in 2017&ndash;2018 to 35% in 2021&ndash;2022. The percentage who currently used nicotine hovered around 50%, as measured by current use of an e-cigarette or combustible cigarette and this percentage did not significantly trend over the study period. The percentage who currently used e-cigarettes exclusively and not combustible cigarettes tripled from 6% in 2017&ndash;2018 to 21% in 2021&ndash;2022. About half of this exclusive e-cigarette group deliberately used e-cigarettes to quit combustible cigarettes, in all years. Dual use of both e-cigarettes and combustible cigarettes significantly increased from 11% in 2017&ndash;2018 to 17% in 2021&ndash;2022. Trends were robust in multivariable regression analyses that controlled demographics.</p>
</sec>
<sec><st>Conclusion</st>
<p>Among young adults who had smoked in adolescence, a 10-point decline in cigarette prevalence from 2017 to 2022 coincided with a 7-point increase in the percentage who deliberately used e-cigarettes to quit combustible cigarettes.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Miech, R., Leventhal, A., Patrick, M., Rodriguez, N.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2024-059018</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2024-059018</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Trends in use of cigarettes and e-cigarettes among young adults who had smoked in adolescence: 2017-2022]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Original research</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>345</prism:startingPage>
<prism:endingPage>350</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/351?rss=1">
<title><![CDATA[How do clinicians address vaping in an illegal context? A qualitative Singapore study]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/351?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>Despite a strict vaping ban also covering purchase, use and possession, vaping has become more prevalent in Singapore. As more countries seek to regulate vaping, with no tailored services or guidelines for vaping cessation, clinicians may face additional challenges in identifying or treating vaping cases due to stigma or patients&rsquo; reluctance to disclose their vaping. Few studies have explored how clinicians identify or manage vaping cases in a context where vaping is heavily regulated or stigmatised.</p>
</sec>
<sec><st>Methods</st>
<p>We conducted semistructured interviews with 12 Singapore practitioners from pharmacy, psychology, respiratory medicine, smoking cessation or youth welfare settings, all of whom had encountered vaping cases in their practice. Interviews explored how they manage vaping cases. We analysed data using inductive thematic methods.</p>
</sec>
<sec><st>Results</st>
<p>Patients were described as reluctant to disclose their vaping for fear of being reported to authorities, and some clinicians were unsure of their duty to report, making it challenging to identify vaping cases. Variability in usage patterns and inaccurate e-liquid labelling posed difficulties in estimating nicotine dependence, leaving practitioners to trial and error or to adapt from smoking cessation guidelines. Tailored quit support for people who vape was lacking, especially in the form of subsidised nicotine replacement therapy.</p>
</sec>
<sec><st>Conclusion</st>
<p>Even in contexts where vaping is heavily regulated, given the rising incidence of vaping globally, it is important to record patients&rsquo; vaping history as part of routine practice and to provide services to help people quit vaping without facing stigma or legal repercussions because of their vaping.</p>
</sec>
]]></description>
<dc:creator><![CDATA[van der Eijk, Y., Kwok, W. Y., Tan, G. P. P.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2024-058996</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2024-058996</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[How do clinicians address vaping in an illegal context? A qualitative Singapore study]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Original research</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>351</prism:startingPage>
<prism:endingPage>357</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/358?rss=1">
<title><![CDATA[Impact of Instagram and TikTok influencer marketing on perceptions of e-cigarettes and perceptions of influencers in young adults: a randomised survey-based experiment]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/358?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>Pairing e-cigarettes with healthy lifestyle contexts in influencers&rsquo; promotional social media posts may increase e-cigarette use risk among young adults. This study examined the effects of e-cigarette and healthy lifestyle content on young adults&rsquo; perceptions of influencer credibility, harm perceptions of, and susceptibility to use, e-cigarettes.</p>
</sec>
<sec><st>Methods</st>
<p>In this survey-based online, repeated-measures experiment (2023), California young adults (N=1494, M<SUB>age</SUB>=23 (SD=1.8); 63% female, 51% Hispanic) were randomly shown 10 (total) Instagram and TikTok videos, featuring influencers promoting e-cigarettes alongside healthy lifestyle activities (experimental group), or a healthy lifestyle activity alone (control). After watching each video, participants rated perceived influencer credibility (eg, honesty). After watching all videos, harm perceptions of e-cigarettes were assessed among all participants and susceptibility to e-cigarette use was assessed among e-cigarette never-users. Harm perceptions and susceptibility outcomes were compared between groups (experimental vs control) and between participants who perceived influencers as credible versus non-credible, using binomial generalised linear mixed effects models.</p>
</sec>
<sec><st>Results</st>
<p>Participants in the experimental group were more likely to report lower harm perceptions (adjusted OR (AOR) 1.12; 95% CI 1.03; 1.21) and higher susceptibility to e-cigarette use (AOR 1.22, 95% CI 1.11; 1.34), than participants in the control condition. Similar results were found when influencers were perceived as credible, but not when they were perceived as non-credible.</p>
</sec>
<sec><st>Conclusions</st>
<p>Social media influencers&rsquo; posts promoting e-cigarette use along with healthy activities may contribute to young adult e-cigarette use. Decreasing perceived credibility of influencers could decrease the negative effects of their promotional posts.</p>
</sec>
<sec><st>Trial registration number</st>
<p>  <A HREF="NCT06433466">NCT06433466</A>.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Vassey, J., Vogel, E. A., Unger, J. B., Cho, J., Bae, D., Donaldson, S. I., Allem, J.-P.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2024-059021</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2024-059021</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Open access]]></dc:subject>
<dc:title><![CDATA[Impact of Instagram and TikTok influencer marketing on perceptions of e-cigarettes and perceptions of influencers in young adults: a randomised survey-based experiment]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Original research</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>358</prism:startingPage>
<prism:endingPage>365</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/366?rss=1">
<title><![CDATA[Association of menthol-flavoured cigarette smoking with all-cause and cause-specific mortality risk]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/366?rss=1</link>
<description><![CDATA[
<sec><st>Introduction</st>
<p>Menthol-flavoured cigarettes remain unregulated in the USA and in many low- and middle-income countries (LMICs) despite their known impacts on smoking uptake and reduced cessation. Yet, evidence about whether menthol cigarettes are associated with higher disease risks than non-menthol cigarettes is inconclusive, and the industry has used this argument to lobby against regulation.</p>
</sec>
<sec><st>Methods</st>
<p>All-cause and cause-specific mortality risk was assessed according to baseline smoking status (current, former and never) and menthol flavour status (menthol and non-menthol) of the cigarette brand smoked for the longest period among 969 349 persons from Cancer Prevention Study-II, a population-based prospective cohort study enrolled in 1982&ndash;1983 with mortality follow-up of 6 years.</p>
</sec>
<sec><st>Results</st>
<p>73 486 and 281 680 persons reported menthol brands and non-menthol brands, respectively, among whom 4071 and 20 738 deaths occurred, respectively. Currently smoking cigarettes, whether menthol or non-menthol brands, was associated with highest mortality risks (eg, all causes: about two times higher risk vs never smoking) but quitting substantially reduced risks for both types. Among persons who formerly smoked, menthol versus non-menthol smoking was associated with an elevated mortality risk of 12% from all-causes, 16% from all cardiovascular diseases, 13% from ischaemic heart disease, and 43% from other heart diseases Among individuals currently smoking, there was no difference in mortality risks for menthol versus non-menthol cigarettes except for elevated risk among those smoking&ge;40 cigarettes per day. Black persons currently smoking menthol versus non-menthol brands had an 88% elevated mortality risk for other heart diseases.</p>
</sec>
<sec><st>Conclusion</st>
<p>Findings of a unique excess mortality risk associated with menthol cigarettes provide additional scientific evidence&mdash;apart from their known impacts on initiation and cessation&mdash;in support of menthol flavour regulation in the USA and similar policies in LMICs. Public communication efforts must reiterate that quitting all cigarette types is the only safe option to reduce disease risk.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Bandi, P., Newton, C., Xue, Z., Thomson, B., Asare, S., Patel, M., Islami, F., Nargis, N., Patel, A. V., Jemal, A., Westmaas, J. L., Diver, W. R.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2024-059020</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2024-059020</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Association of menthol-flavoured cigarette smoking with all-cause and cause-specific mortality risk]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Original research</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>366</prism:startingPage>
<prism:endingPage>374</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/375?rss=1">
<title><![CDATA[Assessing the effects of minimum floor price laws on tobacco use among youth in the state of Virginia, USA: an agent-based simulation approach]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/375?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>Preventing youth exposure to cigarette smoking is a public health priority. One of the most effective ways to reduce tobacco use is to increase the prices of tobacco products. Minimum floor price laws (MFPLs) are a relatively new but more feasible strategy that sets a price below which the product cannot be sold. We aim to examine the effects of minimum floor prices (MFPs) on tobacco use among youth in Virginia.</p>
</sec>
<sec><st>Methods</st>
<p>An agent-based modelling (ABM) was developed from bottom-up to evaluate the influence of increasing the cigarette MFPs on middle and high school students&rsquo; smoking behaviour in the state of Virginia. A rational-addiction model was integrated to model the smoking decision of youth under the dynamic utility maximisation framework within the ABM.</p>
</sec>
<sec><st>Results</st>
<p>The model predicted that every 10% increase in the MFP in Virginia could prevent 2232 8th graders and 1890 12th graders from cigarette smoking, a 2.4% and 1.8% reduction in median smoking prevalence. For students who smoked, 8th and 12th graders would consume 0.36 and 0.45 fewer cigarettes per smoking day if experiencing a 10% increase in the MFP from the baseline US$7.50 to US$8.30. The MFP level that produces the maximal response was estimated to be between 10% and 30%.</p>
</sec>
<sec><st>Conclusions</st>
<p>MFPLs provide local jurisdictions with a potentially effective strategy to reduce tobacco use and mitigate-related harms among youth.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Lin, S.-Y., Purohit, H., Koch, R., Barnes, A. J., Hayes, R. B., Zhao, X., Xue, H.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2024-058801</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2024-058801</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Assessing the effects of minimum floor price laws on tobacco use among youth in the state of Virginia, USA: an agent-based simulation approach]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Original research</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>375</prism:startingPage>
<prism:endingPage>381</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/382?rss=1">
<title><![CDATA[Vaping cessation interventions: a systematic review and meta-analysis]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/382?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>Electronic nicotine delivery systems (ENDS), such as e-cigarettes, have surged in popularity. While long-term risks remain unclear, known dangers include nicotine addiction, E-cigarette or Vaping Use-Associated Lung Injury and potential extrapulmonary effects on the heart, immune system and neurodevelopment. Addressing ENDS addiction may require strategies akin to smoking cessation. However, evidence is lacking; there are no currently approved vaping-cessation aids. The objective of this review is to summarise the available literature addressing interventions for vaping cessation.</p>
</sec>
<sec><st>Data sources and study selection</st>
<p>A librarian-assisted search was conducted in MEDLINE, Embase and Scopus, as well as preprints in Europe PMC, Open Science Framework, and the grey literature searches until January 2024. Six included studies used self-report methods to determine the abstinence rate, while one study used cotinine-level-verified self-reported abstinence. We included randomised controlled trials (RCTs) that examine &lsquo;rates of vaping cessation&rsquo; outcomes. An intention-to-treat approach was used for data extraction, and random-effects meta-analyses models were applied.</p>
</sec>
<sec><st>Data synthesis</st>
<p>Seven RCTs were included, which studied pharmacological therapy, digital interventions and/or educational content. The primary meta-analyses demonstrated a statistically significant increase in the odds of achieving 7-day point prevalence abstinence (PPA) (OR 1.52, 95% CI 1.15 to 2.01, number of participants=3244, moderate-certainty) and continuous abstinence (OR 2.71, 95% CI 1.31 to 5.61, number of participants=164, low-certainty) following intervention. A non-significant increase in odds was noted at 30-day PPA (OR 1.32, 95% CI 0.72 to 2.42, number of participants=1994, very low certainty).</p>
</sec>
<sec><st>Conclusions</st>
<p>Vaping cessation interventions increase 7-day PPA rates at 1&ndash;12 months follow-up and this was consistent across prespecified subgroup analyses of the intervention type, outcome and duration of follow-up. More high-quality studies with reproducible findings are needed to enhance the certainty of the evidence and guide clinical interventions.</p>
</sec>
<sec><st>PROSPERO registration number</st>
<p>CRD42022383670.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Heshmati, J., Pandey, A., Benjamen, J., Furqan, M., Salman, M., Visintini, S., Mullen, K.-A., Guyatt, G., Pipe, A. L., Mir, H.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2024-058798</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2024-058798</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Open access]]></dc:subject>
<dc:title><![CDATA[Vaping cessation interventions: a systematic review and meta-analysis]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Systematic review</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>382</prism:startingPage>
<prism:endingPage>390</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/391?rss=1">
<title><![CDATA[Impact of heated tobacco products on biomarkers of potential harm and adverse events: a systematic review and meta-analysis]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/391?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To systematically review available data on the effects of heated tobacco products (HTPs) on biomarkers of potential harm (BoPH) and adverse events, including comparison to cigarettes, e-cigarettes and smoking abstinence.</p>
</sec>
<sec><st>Data sources</st>
<p>Web of Science, Scopus, MedRxiv, ClinicalTrials.gov, ICTRP database and HTP manufacturer libraries were searched from January 2010 to December 2024.</p>
</sec>
<sec><st>Study selection</st>
<p>Included studies were interventional clinical trials of any design that measured BoPH or adverse events in adults assigned a marketed HTP and another assigned either cigarettes, e-cigarettes or smoking abstinence.</p>
</sec>
<sec><st>Data extraction</st>
<p>Two reviewers independently extracted data into a predesigned form and assessed risk of bias using Cochrane&rsquo;s Risk of Bias tool version 1.</p>
</sec>
<sec><st>Data synthesis</st>
<p>BoPH data were synthesised using effect direction plots. A random-effects model was used to calculate pooled risk ratios for adverse event data. 40 studies (10 independent, 29 industry-affiliated and 1 of unclear affiliation) were included. Only nine studies lasted longer than 5 days. 19 involved using the intervention just once. Risk of bias was high for 32 studies and unclear for 8. Data on 143 BoPH indicated short-term HTP use had mixed effects compared with cigarettes, e-cigarettes and smoking abstinence. The rate of adverse event reporting was not significantly different between HTP and any comparator group.</p>
</sec>
<sec><st>Conclusions</st>
<p>Despite a growing evidence base, significant limitations hinder interpretation of the data, which do not yet provide clear indication of harm or benefit, even compared with cigarettes. Longer, better quality studies independent of tobacco industry funding are needed to determine the health impacts of HTPs.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Braznell, S., Dance, S., Hartmann-Boyce, J., Gilmore, A.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2024-059000</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2024-059000</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Open access]]></dc:subject>
<dc:title><![CDATA[Impact of heated tobacco products on biomarkers of potential harm and adverse events: a systematic review and meta-analysis]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Systematic review</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>391</prism:startingPage>
<prism:endingPage>403</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/404?rss=1">
<title><![CDATA[Online retailer noncompliance to e-cigarette excise tax and tobacco licensing laws]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/404?rss=1</link>
<description><![CDATA[
<sec><st>Introduction</st>
<p>Tax non-compliance by online vaping retailers undermines excise taxes designed to reduce vaping rates and fund prevention efforts. Despite California&rsquo;s 12.5% Electronic Cigarette Excise Tax and federal mandates under the Prevent All Cigarette Trafficking Act, online vaping retailers&rsquo; adherence to excise taxes remains unclear. This study assessed excise tax compliance among online vaping retailers shipping products to California consumers.</p>
</sec>
<sec><st>Methods</st>
<p>156 purchase attempts were made from n=78 online vaping retailers shipping to San Diego residential addresses. 16 buyers used their personal billing information and residential addresses. Receipts obtained from their purchases were analysed to determine if retailers charged the required 12.5% tax. Retailer licensing status was verified by comparing retailer information to the state&rsquo;s licensed business list using geolocation and approximate string matching. Differences in compliance rates were compared using <sup>2</sup> and Fisher&rsquo;s exact tests.</p>
</sec>
<sec><st>Results</st>
<p>Of the n=58 retailers with receipts, 84.5% did not charge the required excise tax. In-state retailers were more likely to be (p&lt;0.001) licensed than out-of-state (4.0%) or international (0.0%), but tax compliance rates did not significantly differ by retailer location (p=0.57)&mdash;intrastate (19.2%), interstate (16.7%) or international (0.0%). Licensed retailers had higher tax compliance (27.3%) than unlicensed ones (9.1%); however, overall compliance was low.</p>
</sec>
<sec><st>Discussion</st>
<p>Many online vape retailers fail to comply with California&rsquo;s excise tax and licensing laws. Low compliance rates indicate existing enforcement mechanisms are not optimised for online sales. Enhancing oversight and enforcement of excise tax laws for online retailers is crucial to reduce tax non-compliance, prevent revenue loss and support public health.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Mejorado, T., Ellis, S., Harati, R. M., Satybaldiyeva, N., Benitez, G., Austin, E. A. C., Leas, E. C.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2024-059161</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2024-059161</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Online retailer noncompliance to e-cigarette excise tax and tobacco licensing laws]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Short report</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>404</prism:startingPage>
<prism:endingPage>407</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/408?rss=1">
<title><![CDATA[How state and local affirmative litigation can rein in illicit flavoured e-cigarettes]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/408?rss=1</link>
<description><![CDATA[ <sec id="s1"><st>Introduction</st> <p>FDA enforcement of e-cigarette regulations is widely regarded as failing.<cross-ref type="bib" refid="R1">1</cross-ref> Because e-cigarettes meet the definition of a &lsquo;new tobacco product&rsquo;, to legally market an e-cigarette in the USA, a manufacturer must submit a premarket tobacco product application (PMTA) to the FDA and receive a written marketing order.<cross-ref type="bib" refid="R2">2 3</cross-ref><cross-ref type="bib" refid="R3"></cross-ref> E-cigarettes that are marketed without an FDA marketing order are considered adulterated, misbranded and unlawful.<cross-ref type="bib" refid="R2">2 3</cross-ref><cross-ref type="bib" refid="R3"></cross-ref> The FDA has issued marketing orders authorising the legal sale of 34 e-cigarette products and devices, including four menthol-flavoured products,<cross-ref type="bib" refid="R4">4</cross-ref> and has denied applications for more than 26 million products.<cross-ref type="bib" refid="R5">5</cross-ref> But even in the absence of more FDA PMTA marketing orders, virtually any visit to a vape shop, convenience store or gas station nationwide reveals open displays of hundreds of brands of flavoured e-cigarettes.<cross-ref type="bib" refid="R6">6&ndash;9</cross-ref><cross-ref type="bib" refid="R7"></cross-ref><cross-ref type="bib"...]]></description>
<dc:creator><![CDATA[Schroth, K. R. J., Proshansky, E.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2025-059284</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2025-059284</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Open access]]></dc:subject>
<dc:title><![CDATA[How state and local affirmative litigation can rein in illicit flavoured e-cigarettes]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Advocacy in action</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>408</prism:startingPage>
<prism:endingPage>411</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/412?rss=1">
<title><![CDATA[Protecting children from second-hand tobacco smoke in the home: the need for a new approach]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/412?rss=1</link>
<description><![CDATA[ <p>Recent decades have seen enormous global success in tackling the harms from breathing second-hand tobacco smoke (SHS). Ireland led the way in introducing national-level smoke-free enclosed public spaces to protect non-smokers from the harms of SHS, and many countries followed suit.<cross-ref type="bib" refid="R1">1</cross-ref> Today, 2.1 billion people across 74 countries benefit from comprehensive smoke-free policies in indoor public places and workplaces and on public transport.<cross-ref type="bib" refid="R2">2</cross-ref> In the UK, for example, the proportion of non-smoking adults who have measurable levels of nicotine in their saliva has fallen from nearly 90% in 1998 to less than 20% in 2016.<cross-ref type="bib" refid="R3">3</cross-ref> Using the same method of assessment, the proportion of children exposed to SHS has reduced by a smaller magnitude, from 86% in 1998 to 35% by 2018.<cross-ref type="bib" refid="R4">4</cross-ref> This commentary makes the case that this gap demonstrates the need for a new approach to protecting children from SHS.</p>...]]></description>
<dc:creator><![CDATA[Semple, S., Tigova, O., Howell, R., Davie, E., Gorini, G., Turner, S. W., Vardavas, C., Clancy, L., Peruga, A., Fernandez, E., O'Donnell, R.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2024-059205</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2024-059205</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Protecting children from second-hand tobacco smoke in the home: the need for a new approach]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Commentary</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>412</prism:startingPage>
<prism:endingPage>414</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/415?rss=1">
<title><![CDATA[Adolescent cigarette and e-cigarette use after the rise of disposable e-cigarettes: interrupted time series study in Germany 2016-2024]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/415?rss=1</link>
<description><![CDATA[ <p>There has been a rapid rise in disposable e-cigarette use in Germany<cross-ref type="bib" refid="R1">1</cross-ref> and England<cross-ref type="bib" refid="R2">2</cross-ref> since June 2021. We examined how this has affected population trends in current use of cigarettes and e-cigarettes among adolescents in Germany.</p> <sec id="s1"><st>Methods</st> <p>We used data from eight waves of the Prevention Radar study (<A HREF="https://www.praeventionsradar.de/">https://www.praeventionsradar.de/</A>). The (online) questionnaire survey is conducted annually between November and February in a convenience sample of general secondary schools in 14 federal states of Germany. Prevalence estimates of monthly e-cigarette and cigarette use from winter 2016/2017 to winter 2023/2024 for early adolescence (11&ndash;14 years) and late adolescence (15&ndash;17 years)<cross-ref type="bib" refid="R3">3</cross-ref> in repeated cross sections. These estimates are based on a total of 103 618 adolescent respondents.</p> <p>An interrupted time series (ITS) design was used.<cross-ref type="bib" refid="R4">4</cross-ref> The interruption is the rise of disposable e-cigarettes on the prevalence of cigarette and e-cigarette use in...]]></description>
<dc:creator><![CDATA[Hanewinkel, R., Hansen, J.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2024-059215</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2024-059215</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Adolescent cigarette and e-cigarette use after the rise of disposable e-cigarettes: interrupted time series study in Germany 2016-2024]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Letter</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>415</prism:startingPage>
<prism:endingPage>416</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/417?rss=1">
<title><![CDATA[Tobacco retailers use of toy displays and cartoons in signage in Australia]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/417?rss=1</link>
<description><![CDATA[ <p>The tobacco industry has a history of targeting children with advertising, including at point of sale.<sup><cross-ref type="bib" refid="R1">1 2</cross-ref><cross-ref type="bib" refid="R2"></cross-ref></sup> Examples include selling toys and confectionery near tobacco products and using images or characters that appeal to children. Selling toys and confectionery near tobacco products has been restricted in some Australian states. For example, Western Australia and Tasmania prohibit the display of specific non-tobacco products, including food and toys, close to tobacco in non-specialist tobacco retail outlets; however, most states do not have comparable laws.<sup><cross-ref type="bib" refid="R3">3</cross-ref></sup> In addition, there are no specific restrictions for the vast majority of tobacco retailers on the use of child-friendly and adolescent-friendly products and imagery by tobacco retailers at their shop entrance, in window displays or in signage. There are also currently no laws in Australia that prevent a child from entering a specialist tobacconist.<sup><cross-ref type="bib" refid="R3">3</cross-ref></sup></p> <p>The importance of the retailing...]]></description>
<dc:creator><![CDATA[Morphett, K., Gartner, C. E.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2024-059102</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2024-059102</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Tobacco retailers use of toy displays and cartoons in signage in Australia]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Industry watch</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>417</prism:startingPage>
<prism:endingPage>418</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/419?rss=1">
<title><![CDATA[IQOS--marketing a tobacco product in the UK]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/419?rss=1</link>
<description><![CDATA[ <p>IQOS is the most popular heated tobacco product (HTP) worldwide, marketed by the world&rsquo;s largest transnational tobacco company, Philip Morris International (PMI).<cross-ref type="bib" refid="R1">1</cross-ref> HTPs comprise two components: an electronic battery-powered device, which does the heating, and a cigarette-like stick, which contains the tobacco. These components are sold separately and often under separate brand names. For example, tobacco sticks for IQOS are called &lsquo;HEETS&rsquo;, &lsquo;TEREA&rsquo; and &lsquo;LEVIA&rsquo;.<cross-ref type="bib" refid="R2">2</cross-ref></p> <p>In the UK, HTPs are regulated as a novel tobacco product,<cross-ref type="bib" refid="R3">3 4</cross-ref><cross-ref type="bib" refid="R4"></cross-ref> but there is some ambiguity as to whether regulations apply to HTPs, and to which parts, that is, only the tobacco-containing components (sticks) or the device too, that does not contain tobacco.<cross-ref type="bib" refid="R5">5</cross-ref> The Department of Health and Social Care has previously stated HTPs are covered by the Tobacco and Related Products Regulations 2016<sup><cross-ref type="bib" refid="R6">6</cross-ref></sup> and Tobacco Advertising and Promotion Act 2002,...]]></description>
<dc:creator><![CDATA[Braznell, S.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2024-059243</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2024-059243</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Open access]]></dc:subject>
<dc:title><![CDATA[IQOS--marketing a tobacco product in the UK]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Ad watch</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>419</prism:startingPage>
<prism:endingPage>420</prism:endingPage>
</item>
<item rdf:about="http://tobaccocontrol.bmj.com/cgi/content/short/35/3/421?rss=1">
<title><![CDATA[Behind the smoke: using authenticity to romanticise cigars]]></title>
<link>http://tobaccocontrol.bmj.com/cgi/content/short/35/3/421?rss=1</link>
<description><![CDATA[ <sec id="s1"><st>AD WATCH</st><sec id="s1-1"><st>Behind the smoke: using authenticity to romanticise cigars</st> <p><I>Authenticity</I> is a core component for creating a distinguished and successful global brand.<cross-ref type="bib" refid="R1">1</cross-ref> Authenticity contributes to a brand&rsquo;s assessed value and comparative strength via a powerful brand association.<cross-ref type="bib" refid="R2">2</cross-ref> Perceptions of authenticity hold important sway in industries where heritage, craftsmanship and exclusivity drive consumer preference. Brand authenticity&mdash;the extent to which consumers perceive a brand as credible, true to its essence and aligned with their values&mdash;is often signalled by claims tied to origin, artisanal practices and narrative coherence.<cross-ref type="bib" refid="R3">3&ndash;5</cross-ref><cross-ref type="bib" refid="R4"></cross-ref><cross-ref type="bib" refid="R5"></cross-ref> Authenticity contributes to consumers perceiving a product as &lsquo;natural&rsquo;, original in design and exceptional.<cross-ref type="bib" refid="R6">6</cross-ref></p> <p>Produced by Korean Tomorrow and Global (KT&amp;G)&mdash;South Korea&rsquo;s market leader and the fifth-largest tobacco company globally&mdash;Bohem Signature cigars highlight &lsquo;authenticity&rsquo; in its marketing communication to romanticise smoking (<cross-ref type="fig" refid="F1">figures 1 and 2</cross-ref><cross-ref type="fig" refid="F2"></cross-ref>).<cross-ref type="bib"...]]></description>
<dc:creator><![CDATA[Lonn, A., Dewhirst, T., Lee, W. B.]]></dc:creator>
<dc:date>2026-05-07T03:10:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/tc-2025-059332</dc:identifier>
<dc:identifier>hwp:master-id:tobaccocontrol;tc-2025-059332</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Behind the smoke: using authenticity to romanticise cigars]]></dc:title>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section>Ad watch</prism:section>
<prism:volume>35</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>421</prism:startingPage>
<prism:endingPage>422</prism:endingPage>
</item>
</rdf:RDF>